PROVECTUS BIOPHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (PVCT) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
PVCT on OTC
Shares outstanding
444,806,861
Price per share
$0.06
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
229,411
Total reported value
$20,417
% of total 13F portfolios
0%
Share change
+600
Value change
+$53
Number of holders
6
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of PROVECTUS BIOPHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (PVCT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Pershing Edward 11% $2,955,354 49,255,894 Pershing Edward 26 Nov 2025
Rodrigues Dominic 5.7% $1,513,233 25,220,549 Dominic Rodrigues 02 Dec 2025

As of 30 Sep 2025, 6 institutional investors reported holding 229,411 shares of PROVECTUS BIOPHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (PVCT). This represents 0.05% of the company’s total 444,806,861 outstanding shares.

Institutional Holders of PROVECTUS BIOPHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (PVCT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 229,411 $20,417 +$53 $0.09 6
2025 Q2 228,811 $17,074 $0.07 6
2025 Q1 228,811 $22,881 $0.10 6
2024 Q4 176,811 $21,225 -$5,000 $0.12 5
2024 Q3 226,811 $22,320 -$196 $0.10 6
2024 Q2 228,811 $28,570 $0.13 6
2024 Q1 178,811 $32,710 $0.18 5
2023 Q4 228,811 $21,859 $0.10 6
2023 Q3 218,620 $18,155 -$865 $0.08 5
2023 Q2 226,270 $25,970 $0.11 6
2023 Q1 226,270 $36,784 $0.16 6
2022 Q4 218,620 $23,232 -$2,000 $0.11 5
2022 Q3 256,650 $12,000 -$2,000 $0.05 6
2022 Q2 292,309 $17,000 -$158,062 $0.06 6
2022 Q1 2,616,923 $176,000 -$1,099 $0.06 6
2021 Q4 2,639,300 $146,000 +$130,000 $0.06 6
2021 Q3 236,520 $15,000 +$8 $0.06 6
2021 Q2 236,857 $16,000 $0.07 6
2021 Q1 236,857 $16,000 +$1,252 $0.07 6
2020 Q4 218,457 $13,000 +$1,000 $0.06 5
2020 Q3 196,000 $16,000 $0 $0.08 4
2020 Q2 197,657 $8,000 +$3,000 $0.04 4
2020 Q1 120,000 $6,000 $0.05 2
2019 Q4 120,000 $7,000 -$1,000 $0.06 2
2019 Q3 130,600 $9,000 $0.07 3
2019 Q2 130,600 $8,000 -$1,000 $0.06 3
2019 Q1 152,600 $9,000 -$1,000 $0.06 4
2018 Q4 170,600 $9,000 -$2,000 $0.05 4
2018 Q3 199,100 $14,000 +$3,000 $0.07 5
2018 Q2 150,600 $11,000 -$1,000 $0.08 3
2018 Q1 169,250 $10,000 $0.06 4
2017 Q4 169,250 $13,000 +$5,000 $0.08 4
2017 Q3 100,000 $3,000 $0.03 1
2017 Q2 100,000 $3,000 -$1,000 $0.03 1
2017 Q1 112,205 $5,000 -$1,000 $0.06 2
2016 Q4 179,500 $4,000 -$1,032,000 $0.02 2
2016 Q3 10,567,842 $1,045,000 +$142,088 $0.10 29
2016 Q2 8,466,294 $3,131,000 -$217,289 $0.37 36
2016 Q1 8,998,709 $3,409,000 -$309,049 $0.38 35
2015 Q4 9,807,578 $3,825,000 -$399,293 $0.39 34
2015 Q3 10,662,835 $6,127,000 -$1,079,739 $0.57 35
2015 Q2 12,127,015 $6,548,771 +$4,252,641 $0.54 30
2015 Q1 4,226,892 $3,443,272 -$543,897 $0.81 31
2014 Q4 4,896,691 $3,914,905 +$570,722 $0.80 34
2014 Q3 4,110,787 $4,188,897 +$2,916,157 $1.02 27
2014 Q2 1,274,256 $1,096,621 +$1,015,621 $0.86 26
2014 Q1 75,000 $185,000 +$89,000 $2.46 4